drugset / Trial / NCT00408798

Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin

NCT00408798

Completed 20 enrolled University of British Columbia
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to examine prospectively the safety and efficacy of Botulinum Toxin A (Botox) injections in the treatment of patients with alopecia areata of the scalp.

Timeline

Start
2007-10
Primary completion
2009-10-30
Completion
2009-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 10 iu Other

Indications